These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3928960)
61. The effect of administration rate on cisplatin-induced emesis. Jordan NS; Schauer PK; Schauer A; Nightingale C; Golub G; Martin RS; Williams HM J Clin Oncol; 1985 Apr; 3(4):559-61. PubMed ID: 3884747 [TBL] [Abstract][Full Text] [Related]
62. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. Graffner C; Lagerström PO; Lundborg P; Rönn O Br J Clin Pharmacol; 1979 Nov; 8(5):469-74. PubMed ID: 508553 [TBL] [Abstract][Full Text] [Related]
63. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536 [TBL] [Abstract][Full Text] [Related]
64. The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum. Kerr DJ; Graham J; Blackie RG; McGovern E; Kelman AW; Cunningham D; Kaye SB Br J Clin Pharmacol; 1985 Oct; 20(4):426-7. PubMed ID: 4074612 [No Abstract] [Full Text] [Related]
65. Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide. Senn HJ; Glaus A; Bachmann-Mettler I J Clin Oncol; 1984 Apr; 2(4):320-2. PubMed ID: 6538593 [TBL] [Abstract][Full Text] [Related]
66. [Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients]. Kagami Y; Nishio M; Narimatsu N; Tomita M; Sakurai T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):807-10. PubMed ID: 2712578 [TBL] [Abstract][Full Text] [Related]
67. Evidence against bicarbonate reabsorption in the ascending limb, particularly as disclosed by free-water clearance studies. Seldin DW; Rosin JM; rector FC Yale J Biol Med; 1975 Sep; 48(4):337-47. PubMed ID: 1202762 [TBL] [Abstract][Full Text] [Related]
68. The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group. Chevallier B Br J Cancer; 1993 Jul; 68(1):176-80. PubMed ID: 8391304 [TBL] [Abstract][Full Text] [Related]
69. Dose-dependent pharmacokinetics of metoclopramide in rat: an effect of hemoperfusion? Tam YK; Axelson JE; McErlane B; Ongley R; Price JD J Pharmacol Exp Ther; 1981 Jun; 217(3):764-9. PubMed ID: 7230005 [No Abstract] [Full Text] [Related]
70. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176 [TBL] [Abstract][Full Text] [Related]
71. The pharmacokinetics of the individual constituents of an aspirin-metoclopramide combination ('Migravess'). Manniche PM; Dinneen LC; Langemark M Curr Med Res Opin; 1984; 9(3):153-6. PubMed ID: 6499509 [TBL] [Abstract][Full Text] [Related]
72. Evaluation of a high pressure liquid chromatographic technique for metoclopramide analysis. Bryson SM; McGovern EM; Gilbert LM J Clin Hosp Pharm; 1984 Sep; 9(3):263-6. PubMed ID: 6490946 [TBL] [Abstract][Full Text] [Related]